Profile Image

Staff Profile

Edit

Career Summary

Biography

Dr. Tooney has a keen interest in understanding the cellular and molecular mechanisms of diseases, so that better diagnoses and treatment strategies can be developed. Dr. Tooneys research background during his PhD and postdoctoral work was in cancer biology where he gained experience in cellular and molecular biology techniques. As a post-doctoral scientist at the University of Wisconsin (1995-1998), Dr. Tooney investigated the biology of the extracellular matrix protein thrombospondin and published for the first time the expression of thrombospondin-2 in the developing mouse embryo.

In March 1998, with a growing interest in mental illness and a desire to develop his knowledge and skills in neuroscience, Dr. Tooney took the opportunity to focus on the neurobiology of schizophrenia and joined the Neuroscience Institute of Schizophrenia and Allied Disorders (NISAD). As a NISAD Research Officer (1998-2000), Dr. Tooney investigated the density of GABAergic interneurons in the prefrontal cortex but observed no significant changes in schizophrenia (PT4). He also investigated the expression of tachykinin receptors (putative targets for new treatments in mental illness) in schizophrenia and described the localisation of the NK1 receptors in the human prefrontal cortex for the first time. Dr. Tooney observed a significant increase in the density of NK1 receptor-like immunoreactivity in the prefrontal cortex in schizophrenia (PT5). In a follow-up guinea-pig study of the effects of antipsychotic drugs on the NK1 receptor, Dr. Tooney demonstrated that this increase was likely to be due to drug treatment effects (PT3). Dr. Tooney gave oral presentations of this work at 4 National (2 as invited speaker ASBP, APPS) and one International conference (ICOSR; invited to give an oral presentation).

As a NISAD Senior Research officer (2000-2004), Dr. Tooney established a collaboration with Prof. Rodney Scott, Prof. Pat Michie, A/Prof. Ullrich Schall and Dr. Pablo Moscato from the University of Newcastle to study the genetics of schizophrenia, with the aim of using genetics, endophenotypes and neuroimaging measures to further the understanding of schizophrenia, develop a biological means for diagnosing the disorder and identify new targets for drug discovery. Dr. Tooney wrote grant applications that attracted funding to establish microarray technology and then conduct a pilot project investigating gene expression in schizophrenia from NISAD ($15,000; 2002) and the Hunter Medical Research Institutes (HMRI) Adamstown Lions Club Young Investigator Award ($21,000; 2001-03) and the HMRI Clinical Neuroscience Program ($110,000 2001-03). This project identified changes in the expression of brain-related genes in peripheral blood lymphocytes in schizophrenia (PT1). Dr. Tooney and his collaborators coupled gene expression profiling with demographic, clinical and neurobiological measures, and showed that this approach has the ability to identify subtypes of schizophrenia (PT1).

In 2002 Dr. Tooney established a program of research to investigate gene expression changes in post-mortem brains in schizophrenia to further the understanding of the molecular changes in schizophrenia, which is essential for the identification of new drug targets. Studies in the amygdala from schizophrenia subjects identified novel changes in genes involved in the cytomatrix active zone of the synapse, which controls vesicle release (PT8). Studies in the superior temporal gyrus have identified changes in the expression of three genes identified in the peripheral blood lymphocyte study described above and two important schizophrenia candidate genes, RGS4 and COMT.

From 2003 to present, Dr. Tooney played a major role in establishing and managing the Hunter DNA Bank for Schizophrenia and Allied Disorders. He is an associate investigator and integral member of the national consortium lead by Prof. Vaughan Carr that was awarded an NHMRC enabling grant ($1.75 million; 2006-2010) for t

Qualifications

  • PhD, University of Newcastle, 27/04/1995
  • Bachelor of Science (Honours), University of Newcastle, 11/05/1990

Research

Research keywords

  • Genetics
  • Neuroscience
  • Schizophrenia

Research expertise

Dr. Tooney has a keen interest in understanding the cellular and molecular mechanisms of diseases, so that better diagnoses and treatment strategies can be developed. His research background during his PhD and postdoctoral work was in cancer biology where he gained experience in cellular/molecular biology techniques. He spent 3 years as a post-doctoral scientist at the University of Wisconsin (1995-1998) investigating the extracellular matrix protein thrombospondin-2. In March 1998, Dr. Tooney took the opportunity to return to Australia and focus on the neurobiology of schizophrenia and joined the Neuroscience Institute of Schizophrenia and Allied Disorders (NISAD). As a NISAD Research Officer (1998-2000), Dr. Tooney investigated GABAergic interneurons and the expression of tachykinin receptors in the prefrontal cortex (PFC) in schizophrenia. He described the localisation of the NK1 receptors in the human PFC for the first time, observing a significant increase in NK1 receptor-like immunoreactivity in the PFC in schizophrenia. In a follow-up guinea-pig study, Dr. Tooney demonstrated that this increase was likely to be due to antipsychotic drug treatment effects. As a NISAD Senior Research Officer (2000-2004), Dr. Tooney established a collaboration with Prof. Rodney Scott, Prof. Pat Michie, A/Prof. Ullrich Schall and Dr. Pablo Moscato from the University of Newcastle to study the genetics of schizophrenia, with the aim of using genetics, endophenotypes and neuroimaging measures to further the understanding of schizophrenia, develop a biological means for diagnosing the disorder and identify new targets for drug discovery. Using microarray technology, this project identified changes in the expression of brain-related genes in peripheral blood lymphocytes in schizophrenia and showed that this approach has the ability to identify subtypes of schizophrenia. In 2002 Dr. Tooney applied this technology to post-mortem brains identifying novel changes in many genes in schizophrenia. Dr. Tooney recruited Dr. Murray Cairns to his laboratory to investigate why these gene expression changes occur in schizophrenia using functional genomic approaches. This research has identified miRNAs that are dysregulated in schizophrenia. From 2003 to present, Dr. Tooney played a major role in establishing and managing the Hunter DNA Bank for Schizophrenia and Allied Disorders and the Australian Schizophrenia Research Bank (ASRB, a national consortium lead by Prof. Vaughan Carr that was awarded an NHMRC enabling grant ($1.75 million; 2006-2010). Dr. Tooney was appointed Lecturer in Pharmacology in the School of Biomedical Sciences, University of Newcastle in July 2004 and continues to focus on the molecular and cellular mechanisms underlying schizophrenia to develop better diagnosis and treatment strategies. Since switching from full-time research and becoming an independent academic in July 2004, Dr. Tooney has published 6 peer-reviewed papers, submitted three further manuscripts for consideration and is a chief investigator on successful external funding applications totalling over $0.5 million. During this time, Dr Tooney co-supervised three honours students (all received Honours Class I) and two PhD students to successful completion. Dr. Tooney currently co-supervises four PhD and one Honours student.

Fields of Research

CodeDescriptionPercentage
060199Biochemistry And Cell Biology Not Elsewhere Classified40
060400Genetics30
110900Neurosciences30

Memberships

Body relevant to professional practice.

  • General Member - Australian Neuroscience Society

Other

  • Affiliated Scientist - Schizophrenia Research Institute

Awards

Research Award.

1991Australian Postgraduate Research Award
University of Newcastle (Australia)

Invitations

Tachykinin NK1 receptor immunoreactivity is increased in the prefrontal cortex in schizophrenia
International Congress On Schizophrenia Research, Canada (Invited to give oral preseantation)
2001

Collaboration

My primary research interests are in the udnerstanding of the cellular and molecular mechanisms of disease so that better diagnoses and treatment strategies can be developed. Since Feb 1998 I developed a growing interest in mental illness and focused on the neurobiology of schizophrenia encompassing projects investigating changes in the cortex to neurons and their gene expression, right down to the genetics of the disorder. Dr. Tooney played a role in establishing the Australian Schizophrenia Research Bank (ASRB) and the Neurobehavioural Genetics Unit that has the aim of conducting large-scale genetic analyses on blood samples from individuals with schizophrenia. Dr. Tooney applies a range of state of the art molecular technologies to RNA and DNA extracted from human brain tissue and peripheral tissues to help understand what causes schizophrenia, develop biological means to diagnose and/or identify who is at-risk of developing the disorder and how the genome impacts on treatment of the disorder.

Administrative

Administrative expertise

Dr. Tooney was a member of the Faculty of Health Research Grants Committee that ranked research applications submitted in 2004 for the Research Grants Committees Small Grant Scheme. Dr. Tooney is a member of the Master of Nursing (Nurse Practitioner) Advisory Committee (2005 present) where he represents the School of Biomedical Sciences on this committee to oversee the Master of Nursing (Nurse Practitioner) Program. The primary concern of this committee since late 2005 was the accreditation of the Program with the NSW Nursing and Midwives Board (NMB). The MNB awarded accreditation of the program for the maximum possible time of 4 years. Dr. Tooney is a member of the Institutional Biosafety Committee (IBC; Dec 2005 - present) representing the School of Biomedical Sciences. The IBC oversees all aspects of biosafety for the University, reviews biosafety applications by researchers and provide recommendations on approval of their research projects, inspects laboratories to provide feedback on biosafety requirements. Particularly I was involved in dientifyiing a deficiency in the availability of PC2 level facilities in the Medical Sciences building (MSB). As a consequence, funding to upgrade the facilities has been allocated in 2007. Dr. Tooney is also a member of the Master of Pharmacy Accreditation and Program Review Committee (2006 present). In early 2006, Dr. Rohan Rasiah (Convenor of the Master of Pharmacy Program) asked him to assist with preparing the documentation for preliminary approval and provisional accreditation of the Program by the New Zealand and Australian Pharmacy Schools Accreditation Committee (NAPSAC). Documentation from the coordinators of the science-based courses within the Program was then collected and collated to assist Dr. Rasiah with the integration of this information with that from the Pharmacy based courses into the accreditation application. Dr. Tooney also reviewed the entire application and made comments and recommendations, as well as assisting with the adaptation of these documents into an interactive CD. NAPSAC sent an evaluation team for a site visit in May 11-12, 2006. Dr. Tooney met with the team, gave presentations and answered questions regarding the molecular- and pharmacology-based courses within the Program. NAPSAC granted preliminary and provisional accreditation to the Master of Pharmacy Program. Dr. Tooney was also a member of the School of Biomedical Sciences Working Party for the NISAD Chair in Schizophrenia Research Chair application (2005). NISAD called for expressions of interest from NSW Universities to host the Inaugural NISAD Chair in Schizophrenia Research worth $1 million/year. Due to strong collaborations with NISAD, Prof. Mike Calford (then Head of School of Biomedical Sciences; PVC Research) asked Dr. Tooney to attend a meeting of senior academics in the School of Biomedical Sciences regarding the bid to host the Chair at the University of Newcastle. Dr. Tooney gave advice on what type of research NISAD was expecting the Chair to be involved with and also provided information and comments on the initial application. The Newcastle bid was one of two applications short-listed for interview, but was not successful.

Teaching

Teaching keywords

  • Pharmacology

Teaching expertise

Dr. Tooney has expertise in teaching basic cell biology and pharmacology. Dr. Tooney developed pharmacology content for the new Bachelor of Nursing program, assisted with the re-development of Pharmacology content for the Master of Pharmacy program, Assisted with the re-develolopment of the Bachelor of Biomedical Sciences program by developing and delivering a course in Human Pharmacology for the first time, coordinated 4 Pharmacology courses in three different degree Programs (Bachelor of Biomedical Sciences, Master of Pharmacy, Master of Nursing (Nurse Practitioner), supervised/supervisor of 6 PhD students (2 completed, supervisor of 4 honours students (3 received first class honours). Dr. Tooney has delivered pharmacology content into 6 Degree programs serviced by the Faculty of Health at teh university of Newcastle.

Edit

Publications

No publications.

Edit

Grants and Funding

Summary

Number of grants46
Total funding$3,957,888

For project grants received where the lead institution is other than the University of Newcastle, details are shown in italics.

- Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2013 (2 grants)

Leica TP 1020 Automatic Tissue Processor for histology applications$35,000
Funding Body: NHMRC (National Health & Medical Research Council)

Ultra-Low Temperature Cryogenic Freezer$24,596
Funding Body: NHMRC (National Health & Medical Research Council)

2012 (2 grants)

Testing for N-methyl-D-aspartate (NMDA) receptor antibodies in a large Australian cohort of schizophrenia patients$30,000
Funding Body: Hunter Medical Research Institute

Project Team
Associate Professor Paul Tooney, Mr Paul Rasser, Mr Tim Ehlkes, Emeritus Professor Patricia Michie, Professor Ulli Schall, Doctor Carmel Loughland
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$30,00020122012
GNo:G1200854

Testing for N-methyl-D-aspartate (NMDA) receptor antibodies in a large Australian cohort of schizophrenia patients$10,000
Funding Body: Schizophrenia Research Institute

Project Team
Associate Professor Paul Tooney, Associate Professor Ute Vollmer-Conna, Mr Paul Rasser, Mr Tim Ehlkes, Emeritus Professor Patricia Michie, Professor Ulli Schall, Doctor Carmel Loughland
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$10,00020122013
GNo:G1201020

2011 (2 grants)

Emerging Research Leaders Program 2011$15,000
Funding Body: University of Newcastle

Project Team
Associate Professor Paul Tooney
SchemeRole
Emerging Research Leaders ProgramChief Investigator
Total AmountFunding StartFunding Finish
$15,00020112011
GNo:G1101112

IMPLEN NanoPhotometer pearl$10,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Doctor Murray Cairns, Associate Professor Paul Tooney, Associate Professor Alan Brichta, Professor John Rostas, Emeritus Professor Patricia Michie, Conjoint Professor Keith Jones, Professor Ulli Schall, Associate Professor Phillip Dickson, Doctor Frederick Walker, Doctor Rick Thorne, Doctor Chris Dayas, Doctor Nikki Verrills, Doctor Janet Holt, Doctor Severine Roselli, Doctor Kathryn Skelding, Doctor Jude Weidenhofer, Associate Professor Liz Milward, Doctor Charles De Bock, Doctor Julie Merriman-Jones, Doctor Jing Qin Wu, Doctor Bing Liu, Mr Dan Johnstone, Ms Belinda Goldie, Ms Natalie Beveridge
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$10,00020112011
GNo:G1100030

2010 (7 grants)

Molecular and cellular characterisation of schizophrenia associated dysfunction in microRNA biogenesis$478,500
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Doctor Murray Cairns, Professor Rodney Scott, Associate Professor Paul Tooney, Professor John Rostas, Associate Professor Alan Brichta
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$478,50020102012
GNo:G0190196

Laser microdissection microscopy system for cell and development biology$350,000
Funding Body: ARC (Australian Research Council)

Laser microdissection microscopy system for cell and development biology$215,000
Funding Body: University of Newcastle

Targeting neuroinflammation to improve the efficacy of antidepressant drugs$50,000
Funding Body: BellBerry Limited

Project Team
Doctor Frederick Walker, Dr Kathryn Buller, Associate Professor Paul Tooney
SchemeRole
Near MissInvestigator
Total AmountFunding StartFunding Finish
$50,00020102012
GNo:G0900219

ABI 7500 Real Time PCR System $34,000
Funding Body: NHMRC (National Health & Medical Research Council)

Analysis of schizophrenia-associated gene and mircoRNA signatures in purified CD4 and CD8 positive T-cells$25,000
Funding Body: Hunter Children`s Research Foundation

Project Team
Doctor Murray Cairns, Doctor Jing Qin Wu, Associate Professor Paul Tooney, Professor Rodney Scott
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$25,00020102010
GNo:G0900188

Do chiropractic spinal adjustments modulate brain derived neurotrophic factor levels in the brain - a study in the rodent$21,715
Funding Body: Australian Spinal Research Foundation

Project Team
Associate Professor Philip Bolton, Associate Professor Paul Tooney
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$21,71520102011
GNo:G0190387

2009 (4 grants)

An Advanced Mass Spectrometry Facility for Applications in Proteomics and Organic Chemistry$495,000
Funding Body: ARC (Australian Research Council)

An Advanced Mass Spectrometry Facility for Applications in Proteomics and Organic Chemistry$50,000
Funding Body: ARC (Australian Research Council)

Investigation of schizophrenia associated gene and miRNA expression in the dorsolateral prefrontal cortex$19,719
Funding Body: Schizophrenia Research Institute

Project Team
Doctor Murray Cairns, Associate Professor Paul Tooney
SchemeRole
Postgraduate Research ScholarshipInvestigator
Total AmountFunding StartFunding Finish
$19,71920092012
GNo:G0190436

Leica VT1200S - Fully automated vibrating blade microtome$16,209
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Robert Callister, Associate Professor Alan Brichta, Conjoint Professor Keith Jones, Associate Professor Jon Hirst, Doctor Brett Graham, Associate Professor Philip Bolton, Doctor Phil Jobling, Associate Professor Paul Tooney, Doctor Angela McPherson, Doctor Rebecca Lim, Doctor Ramatis De Oliveira, Mr Matthew Walsh
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$16,20920092009
GNo:G0189842

2008 (4 grants)

Micro-array gene expression and grey matter changes in treatment - naive schizophrenia patients in Sri Lanka$56,000
Funding Body: Schizophrenia Research Institute

Project Team
Professor Ulli Schall, Associate Professor Paul Tooney
SchemeRole
Postgraduate Research ScholarshipInvestigator
Total AmountFunding StartFunding Finish
$56,00020082009
GNo:G0189009

A road map of schizophrenia associated with gene and miRNA expression in the dorsolateral prefrontal cortex$25,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Murray Cairns, Associate Professor Paul Tooney
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$25,00020082008
GNo:G0188461

Brain Science and Young People's Mental Health: A gene expression study in young people at ultra high risk of developing schizophrenia$25,000
Funding Body: Hunter Medical Research Institute

Project Team
Associate Professor Paul Tooney, Emeritus Professor Patricia Michie, Professor Ulli Schall, Professor Rodney Scott, Associate Professor Helen Stain, Doctor Rebbekah Atkinson
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$25,00020082008
GNo:G0188475

Investigation of miRNA influence on NRG1 dysregulation in schizophrenia$16,000
Funding Body: Schizophrenia Research Institute

Project Team
Associate Professor Paul Tooney, Doctor Murray Cairns
SchemeRole
Postgraduate Research ScholarshipChief Investigator
Total AmountFunding StartFunding Finish
$16,00020082011
GNo:G0188594

2007 (5 grants)

HMRI Postdoctoral Fellowship in Youth Mental Health Research$150,000
Funding Body: Hunter Medical Research Institute

Project Team
Professor Ulli Schall, Emeritus Professor Patricia Michie, Associate Professor Paul Tooney, Associate Professor Helen Stain, Doctor Carmel Loughland, Conjoint Professor Vaughan Carr
SchemeRole
Postdoctoral FellowshipInvestigator
Total AmountFunding StartFunding Finish
$150,00020072009
GNo:G0188274

Gene silencing in the pathogenesis of schizophrenia$23,750
Funding Body: Schizophrenia Research Institute

Project Team
Associate Professor Paul Tooney, Doctor Murray Cairns
SchemeRole
Postgraduate Research ScholarshipChief Investigator
Total AmountFunding StartFunding Finish
$23,75020072010
GNo:G0187724

The functional characterization of schizophrenia-associated non-coding RNA expression$23,750
Funding Body: Schizophrenia Research Institute

Project Team
Associate Professor Paul Tooney, Doctor Murray Cairns
SchemeRole
Postgraduate Research ScholarshipChief Investigator
Total AmountFunding StartFunding Finish
$23,75020072010
GNo:G0187725

Investigation of Genetic and epigenetic mechanism underlying dysregulation of RGS4 in schizophrenia$8,702
Funding Body: University of Newcastle

Project Team
Associate Professor Paul Tooney, Doctor Murray Cairns
SchemeRole
Pilot GrantChief Investigator
Total AmountFunding StartFunding Finish
$8,70220072007
GNo:G0187862

International Congress on Schizphrenia Research, The Broadmoor, Colorado Sprins, Colorado, 28/3/2007 - 01/04/2007$2,500
Funding Body: University of Newcastle

Project Team
Associate Professor Paul Tooney
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,50020072007
GNo:G0187387

2006 (2 grants)

PRC - Priority Research Centre for Bioinformatics, Biomarker Discovery & Information-Based Medicine (CIBM)$621,143
Funding Body: University of Newcastle

Project Team
Professor Pablo Moscato, Professor Rodney Scott, Professor John Rostas, Professor John Forbes, Conjoint Professor Peter Hersey, Conjoint Professor Stephen Ackland, Conjoint Professor Wayne Smith, Emeritus Professor Peter Dunkley, Conjoint Professor Leonie Ashman, Professor John Attia, Associate Professor Phillip Dickson, Associate Professor Liz Milward, Professor Alistair Sim, Associate Professor Paul Tooney, Associate Professor Regina Berretta, Conjoint Professor David Sibbritt, Conjoint Professor Chris Levi, Professor Xu Dong Zhang, Conjoint Associate Professor Patricia Crock, Conjoint Associate Professor Jeannette Lechner-Scott
SchemeRole
Priority Research CentreInvestigator
Total AmountFunding StartFunding Finish
$621,14320062013
GNo:G0186919

Investigation of miRNAs in schizophrenia$20,000
Funding Body: University of Newcastle

Project Team
Doctor Murray Cairns, Associate Professor Paul Tooney, Professor Rodney Scott
SchemeRole
Pilot GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020062006
GNo:G0186685

2005 (2 grants)

High throughput proteomics - Thermo Finnigan ProteomeX LCQ Integrated Proteomicis Workstation$207,189
Funding Body: ARC (Australian Research Council)

Schizophrenia DNA Bank$119,500
Funding Body: Australian Rotary Health

SchemeRole
ProjectInvestigator
Total AmountFunding StartFunding Finish
$119,50020052006
GNo:17794418

2004 (5 grants)

Senior research Officer Salary$246,800
Funding Body: Schizoprhenia Research Institute (formerly NISAD)

SchemeRole
Chief Investigator
Total AmountFunding StartFunding Finish
$246,80020042007
GNo:17794489

Biacore3000-Expansion of Proteomics Facility$187,341
Funding Body: ARC (Australian Research Council)

Project Team
Professor Alistair Sim, Laureate Professor John Aitken, Emeritus Professor Peter Dunkley, Professor John Rostas, Associate Professor Phillip Dickson, Conjoint Professor Leonie Ashman, Professor Roger Smith, Professor Gordon Burns, Professor Adam McCluskey, Associate Professor Paul Tooney, Dr Fraser Ross, Conjoint Professor Ray Rose
SchemeRole
Linkage Infrastructure Equipment & Facilities (LIEF)Investigator
Total AmountFunding StartFunding Finish
$187,34120042004
GNo:G0183030

Analysis of gene expression in psychosis using microarray technology$93,474
Funding Body: Hunter Medical Research Institute

SchemeRole
Brain and Mental Health Reseacrh program Infrastructure fundingChief Investigator
Total AmountFunding StartFunding Finish
$93,47420042006
GNo:17794450

Investigation of the contribution of the use of cannabis in the development of schizophrenia in gentically predisposed individuals$16,000
Funding Body: Hunter Medical Research Institute

Project Team
Dr Fraser Ross, Associate Professor Paul Tooney
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$16,00020042004
GNo:G0183754

Investigation of the contribution of the use of cannabis in the development of schizophrenia in genetically predisposed individuals$5,000
Funding Body: NISAD

SchemeRole
Investigator
Total AmountFunding StartFunding Finish
$5,00020042004
GNo:17794511

2003 (2 grants)

DNA Bank for Schizophrenia Research$15,000
Funding Body: The Percy Baxter Foundation

SchemeRole
Chief Investigator
Total AmountFunding StartFunding Finish
$15,00020032003
GNo:17794571

Assessment of somatosensory function in subjects with schizophrenia: touch, pain and axon reflex flare.$11,000
Funding Body: University of Newcastle

Project Team
Conjoint Professor Loris Chahl, Conjoint Professor Vaughan Carr, Associate Professor Paul Tooney, Doctor Carmel Loughland, Professor Mike Calford
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$11,00020032003
GNo:G0182466

2002 (5 grants)

The Genetics of Schizophrenia.$60,000
Funding Body: Neuroscience Institute of Schizophrenia and Allied Disorders

Project Team
Associate Professor Paul Tooney, Professor Rodney Scott
SchemeRole
Postgraduate Research ScholarshipChief Investigator
Total AmountFunding StartFunding Finish
$60,00020022004
GNo:G0182268

The role of tachykinins and their receptors in schizophrenia: An investigation at a cellular and genetic level.$60,000
Funding Body: Neuroscience Institute of Schizophrenia and Allied Disorders

Project Team
Associate Professor Paul Tooney, Conjoint Professor Loris Chahl, Professor Rodney Scott
SchemeRole
Postgraduate Research ScholarshipChief Investigator
Total AmountFunding StartFunding Finish
$60,00020022004
GNo:G0182269

The development of microarray technology for biomedical research in the Hunter Region.$21,000
Funding Body: Hunter Medical Research Institute

Project Team
Associate Professor Paul Tooney, Mr Douglas Dorahy, Professor Rodney Scott
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$21,00020022004
GNo:G0181184

Equipment for the analysis of gene expression in psychosis using microarray technology$15,000
Funding Body: NISAD

SchemeRole
Chief Investigator
Total AmountFunding StartFunding Finish
$15,00020022002
GNo:17794597

The Effect of chronic treatment with a Tachykinin NK1 receptor antagonist on the stress response to opiod withdrawal in guinea-pigs$9,000
Funding Body: University of Newcastle

Project Team
Conjoint Professor Loris Chahl, Associate Professor Paul Tooney
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$9,00020022002
GNo:G0181266

2001 (2 grants)

Tachykinin NK, receptors in guinea-pig and human limbic systems: role in the response to stress$10,000
Funding Body: University of Newcastle

Project Team
Conjoint Professor Loris Chahl, Associate Professor Paul Tooney
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$10,00020012001
GNo:G0180106

NK1 receptor immunoreactivity is increased in the prefrontal cortex in schizophrenia$1,500
Funding Body: Ian Potter Foundation

SchemeRole
Post-Doctoral Travel GrantsChief Investigator
Total AmountFunding StartFunding Finish
$1,50020012001
GNo:17794627

2000 (2 grants)

Neurolucida Imaging System.$24,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Professor Loris Chahl, Associate Professor Paul Tooney, Emeritus Professor Peter Dunkley, Professor John Rostas
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$24,00020002000
GNo:G0179167

The effects of anti-psychotic drugs on the distribution of tachykinin receptors in Guinea Pig brain.$4,500
Funding Body: University of Newcastle

Project Team
Associate Professor Paul Tooney
SchemeRole
Early Career Researcher GrantChief Investigator
Total AmountFunding StartFunding Finish
$4,50020002000
GNo:G0179335
Edit

Research Supervision

Number of current supervisions1
Total current UoN PhD EFTSL0.5

For supervisions undertaken at an institution other that the University of Newcastle, details are shown in italics, and the institution name is listed below the program name.

Current Supervision

CommencedProposed
Completion
ProgramSupervisor TypeResearch Title
20082012PhD(Experimental Pharmacology)Principal SupervisorFunctional Analysis of Gene and microRNA Expression Profiling in Schizophrenia: Brain, Blood and Antipsychotics

Past Supervision

YearProgramSupervisor TypeResearch Title
2013PhD(Experimental Pharmacology)Co-SupervisorPost-Transcriptional Gene Regulation in Schizophrenia, Antipsychotic Drug Treatment and the Developing Brain
2013PhD (Behavioural Science)Co-SupervisorMicroarray Gene Expression and Cerebral Cortical Grey Matter Changes in Treatment Naive Schizophrenia Patients in Sri Lanka
2013PhD(Experimental Pharmacology)Co-SupervisorGenomic Characterisation of Small RNA-Mediated Post-Transcriptional Gene Regulation
2011PhD(Experimental Pharmacology)Co-SupervisorPost-transcriptional Gene Silencing in Neuronal Differentiation, Development and Schizophrenia
2010PhD (Anatomy)Co-SupervisorCannabinoid Signaling Mechanisms in the Central Nervous System
2006PhD (Medical Biochemistry)Principal SupervisorInvestigation of Cellular and Molecular Changes in the Amygdala in Schizophrenia
2006PhD (Medical Genetics)Co-SupervisorGene Expression Profiling in Schizophrenia
Edit

Associate Professor Paul Tooney

Work Phone(02) 4921 8691
Fax(02) 492 17903
Email
PositionAssociate Professor
School of Biomedical Sciences and Pharmacy
Faculty of Health and Medicine
The University of Newcastle, Australia
Focus AreaPharmacy and Experimental Pharmacology
Office
MS614,
Medical Sciences,
Callaghan
University Drive
Callaghan NSW 2308
Australia
URL:www.newcastle.edu.au/profile/paul-tooney